{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","spread":"27.8","value":"48.8"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"3"}],"units":"Participants"}],"description":"The mean (sd) of the AUC.","dispersionType":"Standard Deviation","groups":[{"description":"Patients receive olaparib PO BID on days 1-28. Cycles repeat every 28 days for 2 years in the absence of disease progression or unacceptable toxicity.","id":"OG000","title":"Treatment (Olaparib)"}],"paramType":"MEAN","populationDescription":"3 of the 6 enrolled patients had PK data available for analysis","reportingStatus":"POSTED","timeFrame":"Up to day 8 of cycle 1","title":"Pharmacokinetics (PK) of Olaparib, Area Under the Curve (AUC)","type":"SECONDARY","unitOfMeasure":"mcg*hr/ml"}